Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...
8d
MedPage Today on MSNInitiating Systemic Therapy for PsoriasisUntil about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...
SESAUA annual meeting featured a bladder cancer session and a presentation by Dr. Joon Kyung Kim discussing an evaluation of ...
Panelists discuss how systemic therapy plays a crucial role in embolization-eligible hepatocellular carcinoma (HCC), ...
Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...
In the ECHELON-3 study, the brentuximab vedotin combination with lenalidomide and rituximab reduced mortality risk by 37% compared with placebo.
Bristol Myers Squibb has won European Commission expanded approval of its CAR-T cell therapy Breyanzi in the blood cancer lymphoma.
Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Breyanzi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results